Precision Medicine Market Boosted by AI Integration and Personalized Treatment Demand | Thermo Fisher Scientific Inc., AstraZeneca, Pfizer Inc., GSK plc, Biogen

The Precision Medicine market landscape is undergoing a transformative shift, driven by rapid technological advancements, evolving consumer behaviors, and intensifying competition across industries. This comprehensive market research report delivers in-depth insights, growth projections, and strategic analysis across key segments, empowering stakeholders with data-driven intelligence. Leveraging advanced analytics, trend forecasting, and competitive benchmarking, the report uncovers critical developments in innovation, emerging technologies, supply chain dynamics, and regulatory frameworks. Whether you're exploring investment opportunities, product development strategies, or expansion into high-growth regions, this report serves as your essential guide to navigating today's dynamic market environment.

Get exclusive insights with our detailed sample report (Corporate Email ID gets priority access): https://www.datamintelligence.com/download-sample/precision-medicine-market?ophp

Precision Medicine Market Growth

Precision Medicine Market reached US$ 98.87 billion in 2024 and is expected to reach US$ 329.73 billion by 2033, growing at a CAGR of 14.8% during the forecast period of 2025-2033.

Comprehensive Insight into Precision Medicine Market Landscape and Growth Trends:

Precision medicine tailors treatment to an individual's genetics, lifestyle, and environment. As healthcare shifts toward personalization, the market is growing rapidly across oncology and rare diseases, supported by biomarker research and advances in genomic technologies.

Major Players Shaping the Competitive Landscape:

F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., AstraZeneca, Pfizer Inc., GSK plc, Biogen, Bristol-Myers Squibb Company, Abbott, Merck & Co., Inc., and BGI, among others.

Important Mergers, Acquisitions, and Market Shifts:

✅ In April 2025, McKesson launched the Precision Care Companion (PCC) to help healthcare cancer practices integrate precision medicine into their routine practice. This consortium of industry experts provides targeted education, technology enhancements, operational best practices, and detailed analytics on biomarker testing rates for different cancer diagnoses.

✅ In January 2025, Caris Life Sciences announced a strategic and comprehensive collaboration with Ontada. Ontada specializes in oncology real-world evidence, clinical education, and point-of-care technologies. Together, the partnership aims to advance molecular research and cancer care, strengthen the healthcare delivery system, and accelerate the adoption of precision medicine.

✅ In March 2024, Mirador Therapeutics launched, securing over $400 million in funding led by ARCH Venture Partners. The startup's mission is to "transform precision medicine for immune-mediated inflammatory and fibrotic diseases," as stated in their announcement. They plan to achieve this by utilizing their proprietary Mirador360 development engine, which will facilitate the rapid advancement of various drug discovery and diagnostic programs.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/precision-medicine-market?ophp

Methodology and Scope:

This Precision Medicine Market report is developed using a robust research methodology that combines primary interviews, insights from industry experts, and verified secondary sources such as company filings, trade journals, and trusted databases. It follows a bottom-up and top-down approach to ensure data accuracy through triangulation. The scope of the report covers current market trends, growth potential, and strategic developments across global and regional markets.

Regional Overview for Precision Medicine Market:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

The Report Includes:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.
➡ Go-to-market Strategy.
➡ Neutral perspective on the market performance.
➡ Customized regional/country reports as per request and country level analysis.
➡ Potential & niche segments and regions exhibiting promising growth covered.

People Also Ask:

➠ What are the global sales, production, consumption, imports, and exports in the Precision Medicine market?
➠ Who are the top manufacturers, and what are their capacity, production, sales, pricing, and revenue stats?
➠ What key opportunities and challenges do vendors face in the Precision Medicine industry?
➠ Which product types, applications, or end-users are driving market growth, and what is their market share?
➠ What are the major growth drivers and restraints of the Precision Medicine market?

Looking For Exclusive Full Report? Get it here: https://www.datamintelligence.com/buy-now-page?report=precision-medicine-market?ophp

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.